These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27611986)

  • 1. Neuromuscular transmission abnormalities in myotonic dystrophy type 1: A neurophysiological study.
    Bombelli F; Lispi L; Porrini SC; Giacanelli M; Terracciano C; Massa R; Petrucci A
    Clin Neurol Neurosurg; 2016 Nov; 150():84-88. PubMed ID: 27611986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of respiratory muscle involvement in myotonic dystrophy type 1.
    Henke C; Spiesshoefer J; Kabitz HJ; Herkenrath S; Randerath W; Brix T; Görlich D; Young P; Boentert M
    Neuromuscul Disord; 2020 Jan; 30(1):17-27. PubMed ID: 31839403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experienced and physiological fatigue in neuromuscular disorders.
    Schillings ML; Kalkman JS; Janssen HM; van Engelen BG; Bleijenberg G; Zwarts MJ
    Clin Neurophysiol; 2007 Feb; 118(2):292-300. PubMed ID: 17166763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1.
    Baldanzi S; Ricci G; Bottari M; Chico L; Simoncini C; Siciliano G
    Arch Ital Biol; 2017 Jul; 155(1-2):43-53. PubMed ID: 28715597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neuromuscular junction disorders in the electromyography laboratory.
    Juel VC
    Neurol Clin; 2012 May; 30(2):621-39. PubMed ID: 22361377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neuromuscular transmission by using monopolar needle electrode.
    Tutkavul K; Baslo MB; Ertas M; Tireli H
    Acta Neurol Scand; 2006 Nov; 114(5):340-5. PubMed ID: 17022783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophy type 1 (DM1) presenting with laryngeal stridor and vocal fold paresis.
    Ahmadian JL; Heller SL; Nishida T; Altman KW
    Muscle Nerve; 2002 Apr; 25(4):616-8. PubMed ID: 11932983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks.
    Naro A; Portaro S; Milardi D; Billeri L; Leo A; Militi D; Bramanti P; Calabrò RS
    J Neuroeng Rehabil; 2019 Sep; 16(1):116. PubMed ID: 31533780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral components of exercise-related fatigability in myotonic dystrophy type 1.
    Boërio D; Lefaucheur JP; Bassez G; Hogrel JY
    Acta Neurol Scand; 2012 Jan; 125(1):38-46. PubMed ID: 22188374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrement in area of muscle responses to repetitive nerve stimulation.
    Lo YL; Dan YF; Leoh TH; Tan YE; Ratnagopal P
    Muscle Nerve; 2003 Apr; 27(4):494-6. PubMed ID: 12661052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.
    Chisari C; Bertolucci F; Dalise S; Rossi B
    J Neuroeng Rehabil; 2013 Aug; 10():94. PubMed ID: 23938156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes.
    Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
    Muscle Nerve; 2017 Jul; 56(1):57-63. PubMed ID: 27784130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of repetitive nerve stimulation in the evaluation of neuromuscular junction disorders.
    Zivković SA; Shipe C
    Am J Electroneurodiagnostic Technol; 2005 Dec; 45(4):248-61. PubMed ID: 16457051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-fiber EMG with concentric electrodes in lambert-eaton myasthenia.
    Guan Y; Ding Q; Liu M; Niu J; Cui L
    Muscle Nerve; 2017 Aug; 56(2):253-257. PubMed ID: 27935068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular excitability properties in myotonic dystrophy type 1.
    Boërio D; Hogrel JY; Bassez G; Lefaucheur JP
    Clin Neurophysiol; 2007 Nov; 118(11):2375-82. PubMed ID: 17890147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Myotonic Dystrophy Type I patient with Predominant Proximal Muscle Weakness without Action Myotonia- A Case Report and Review of Pathology.
    Wu CI; Chien YY; Lee KY
    Acta Neurol Taiwan; 2021 Sep; 30(3)():113-118. PubMed ID: 34841507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fatigue in Parkinson's disease patients with stimulated single fiber electromyography.
    Hwang WJ; Lin TS
    Acta Neurol Scand; 2001 Nov; 104(5):271-4. PubMed ID: 11696020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.